Zuzana Chyra, Ph.D.

Dr. Zuzana Chyra, an accomplished researcher specializing in hematologic malignancies mainly in molecular and cell biology of multiple myeloma and AL amyloidosis. Currently, she is focused on investigating approaches to NK cell-based immunotherapy in her research pursuits.

Dr. Chyra’s extensive experience includes position at renowned institution such as the Jerome Lipper Multiple Myeloma Center at Dana Farber Cancer Institute and Harvard Medical School.

Throughout her academic journey, Dr. Chyra has earned numerous accolades, including the IMS Young Investigator Award and ASH Abstract Achievement Award. Her mobility experiences include internships at reputable centers in London, Italy, and United Kingdom. She is actively engaged in supervising undergraduate students and doctoral fellows, demonstrating her commitment to nurturing future talent. She also holds expertise in project management, ensuring the seamless implementation of research initiatives.


AL amyloidosis, multiple myeloma, NK cell therapy, molecular and cell biology, monoclonal gammopathies

  • 2013-2018, Masaryk University in Brno, Doctor of Philosophy (Ph.D.)
  • 2011 -2013, University of Ostrava, Master’s Degree (Mgr.)
  • 2008 -2011, University of Ostrava, Bachelor’s degree (Bc.)
  • 2021-present – Department of Hematooncology, Faculty of Medicine, University of Ostrava
  • 2021-present – Department of Hematooncology, University Hospital Ostrava
  • 2018-2021 – Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Dana Farber Cancer Institute, Boston, USA
  • 2014-2018 – Department of Clinical Studies, Faculty of Medicine, University of Ostrava
  • 2014-2018 – Department of Hematooncology, University Hospital Ostrava
  • 2013-2014 – Babak Myeloma Group, Faculty of Medicine, Masaryk University, Brno
Eminent awards
  • IMS Young Investigator Award- 19th International myeloma workshop Los Angeles, 2022
  • ASH Abstract Achievement Award, 63nd ASH Annual Meeting & Exposition, Atlanta, 2021
  • Pavel Janssen Czech Myeloma Group Award, 2021
  • IMS Young Investigator Award- 18th International myeloma workshop Vienna, 2021
  • ASH Abstract Achievement Award, 62nd ASH Annual Meeting & Exposition, San Diego, 2020
  • Presidential Award – XVIth International Symposium on Amyloidosis, 2018
  • Rising Stars Award – 15th International myeloma workshop Rome, 2015
Key activities

Molecular cell biology, NK cell therapy, translational research

Membership in scientific societies
  • Czech Myeloma Group (since 2017)
  • International Society of Amyloidosis (since 2018)
  • The European Hematology Association (since 2021)
+420 597 372 065
Scroll to Top